Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis A vaccination efficacy in immunocompromised travelers
NL-OMON26720Not yet recruiting
- Sponsor
- no sponsor fund=initiator=sponsor
- Start
- Mar 2009
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of Hepatitis A virus vaccine in hepatitis A (HAV) (3 arms), sponsored by no sponsor fund=initiator=sponsor. Primary endpoint: Antibody titres after booster vaccination. Planned start Mar 2009; status: not yet recruiting.
02
Drugs
Hepatitis A virus vaccine
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NL-OMON26720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26720.